Loading...

Cannon Tyrone

TitleDirector
InstitutionUniversity of California Los Angeles
DepartmentStaglin Center for Cognitive Neuroscience
Address5586 Franz Hall
Dept of Psychology
Los Angeles CA 90089
Phone310-206-8765
vCardDownload vCard
    Other Positions
    TitleProfessor

    TitleProfessor

    TitleProfessor


    Collapse Research 
    Collapse Research Activities and Funding
    Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
    NIH/NIMH RC1MH088546Sep 30, 2009 - Aug 31, 2012
    Role: Principal Investigator
    Training in Early Detection and Prevention in Psychiatric Disorders
    NIH/NIMH T32MH082719Jul 1, 2009 - Jun 30, 2014
    Role: Co-Principal Investigator
    1/9-Predictors and Mechanisms of Conversion to Psychosis
    NIH/NIMH U01MH081902Jan 1, 2008 - Jun 30, 2019
    Role: Principal Investigator
    Memory Mechanisms and Mental Disorders
    NIH/NIMH RL1MH083269Sep 29, 2007 - Jun 30, 2014
    Role: Principal Investigator
    Working Memory and Social Functioning in Schizophrenia
    NIH/NIMH R01MH065079Jan 1, 2003 - Dec 31, 2008
    Role: Principal Investigator
    Neural Phenotypes for Schizophrenia and Bipolar Disorder
    NIH/NIMH R01MH052857Sep 30, 1995 - Apr 30, 2012
    Role: Principal Investigator
    PRENATAL AND PERINATAL FACTORS IN SCHIZOPHRENIA
    NIH/NIMH R29MH048207May 1, 1992 - Apr 30, 1997
    Role: Principal Investigator
    ANTECEDENTS OF POSITIVE &NEGATIVE SCHIZOPHRENIA
    NIH/NIMH F31MH009929Mar 29, 1990
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Jeffries CD, Perkins DO, Fournier M, Do KQ, Cuenod M, Khadimallah I, Domenici E, Addington J, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW. Networks of blood proteins in the neuroimmunology of schizophrenia. Transl Psychiatry. 2018 Jun 06; 8(1):112. PMID: 29875399.
      View in: PubMed
    2. Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, Hagenaars SP, Ritchie SJ, Marioni RE, Fawns-Ritchie C, Liewald DCM, Okely JA, Ahola-Olli AV, Barnes CLK, Bertram L, Bis JC, Burdick KE, Christoforou A, DeRosse P, Djurovic S, Espeseth T, Giakoumaki S, Giddaluru S, Gustavson DE, Hayward C, Hofer E, Ikram MA, Karlsson R, Knowles E, Lahti J, Leber M, Li S, Mather KA, Melle I, Morris D, Oldmeadow C, Palviainen T, Payton A, Pazoki R, Petrovic K, Reynolds CA, Sargurupremraj M, Scholz M, Smith JA, Smith AV, Terzikhan N, Thalamuthu A, Trompet S, van der Lee SJ, Ware EB, Windham BG, Wright MJ, Yang J, Yu J, Ames D, Amin N, Amouyel P, Andreassen OA, Armstrong NJ, Assareh AA, Attia JR, Attix D, Avramopoulos D, Bennett DA, Böhmer AC, Boyle PA, Brodaty H, Campbell H, Cannon T, Cirulli ET, Congdon E, Conley ED, Corley J, Cox SR, Dale AM, Dehghan A, Dick D, Dickinson D, Eriksson JG, Evangelou E, Faul JD, Ford I, Freimer NA, Gao H, Giegling I, Gillespie NA, Gordon SD, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Hartmann AM, Hatzimanolis A, Heiss G, Holliday EG, Joshi PK, Kähönen M, Kardia SLR, Karlsson I, Kleineidam L, Knopman DS, Kochan NA, Konte B, Kwok JB, Le Hellard S, Lee T, Lehtimäki T, Li SC, Liu T, Koini M, London E, Longstreth WT, Lopez OL, Loukola A, Luck T, Lundervold AJ, Lundquist A, Lyytikäinen LP, Martin NG, Montgomery GW, Murray AD, Need AC, Noordam R, Nyberg L, Ollier W, Papenberg G, Pattie A, Polasek O, Poldrack RA, Psaty BM, Reppermund S, Riedel-Heller SG, Rose RJ, Rotter JI, Roussos P, Rovio SP, Saba Y, Sabb FW, Sachdev PS, Satizabal CL, Schmid M, Scott RJ, Scult MA, Simino J, Slagboom PE, Smyrnis N, Soumaré A, Stefanis NC, Stott DJ, Straub RE, Sundet K, Taylor AM, Taylor KD, Tzoulaki I, Tzourio C, Uitterlinden A, Vitart V, Voineskos AN, Kaprio J, Wagner M, Wagner H, Weinhold L, Wen KH, Widen E, Yang Q, Zhao W, Adams HHH, Arking DE, Bilder RM, Bitsios P, Boerwinkle E, Chiba-Falek O, Corvin A, De Jager PL, Debette S, Donohoe G, Elliott P, Fitzpatrick AL, Gill M, Glahn DC, Hägg S, Hansell NK, Hariri AR, Ikram MK, Jukema JW, Vuoksimaa E, Keller MC, Kremen WS, Launer L, Lindenberger U, Palotie A, Pedersen NL, Pendleton N, Porteous DJ, Räikkönen K, Raitakari OT, Ramirez A, Reinvang I, Rudan I, Schmidt R, Schmidt H, Schofield PW, Schofield PR, Starr JM, Steen VM, Trollor JN, Turner ST, Van Duijn CM, Villringer A, Weinberger DR, Weir DR, Wilson JF, Malhotra A, McIntosh AM, Gale CR, Seshadri S, Mosley TH, Bressler J, Lencz T, Deary IJ. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018 May 29; 9(1):2098. PMID: 29844566.
      View in: PubMed
    3. Davidson CA, Piskulic D, Addington J, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW, Johannesen JK. Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study. Schizophr Res. 2018 May 08. PMID: 29751984.
      View in: PubMed
    4. Widiger T, Cannon T. Introduction. Annu Rev Clin Psychol. 2018 May 07; 14:i-ii. PMID: 29734826.
      View in: PubMed
    5. Freedman R, Brown AS, Cannon T, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, Rush AJ, Tamminga CA, Tohen M, Vieta E, Wisner KL, Xin Y. Can a Framework Be Established for the Safe Use of Ketamine? Am J Psychiatry. 2018 Apr 16; appiajp201818030290. PMID: 29656666.
      View in: PubMed
    6. Zheutlin AB, Chekroud AM, Polimanti R, Gelernter J, Sabb FW, Bilder RM, Freimer N, London ED, Hultman CM, Cannon T. Multivariate Pattern Analysis of Genotype-Phenotype Relationships in Schizophrenia. Schizophr Bull. 2018 Mar 09. PMID: 29534239.
      View in: PubMed
    7. Cao H, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon T. Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI-Based Brain Graphs Across Sites, Sessions, and Paradigms. Cereb Cortex. 2018 Mar 07. PMID: 29522112.
      View in: PubMed
    8. Grazioplene RG, Bearden CE, Subotnik KL, Ventura J, Haut K, Nuechterlein KH, Cannon T. Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia. Neuroimage Clin. 2018; 18:608-616. PMID: 29845009.
      View in: PubMed
    9. Woods SW, Powers AR, Taylor JH, Davidson CA, Johannesen JK, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups. Schizophr Bull. 2018 Feb 15; 44(2):254-263. PMID: 29036402.
      View in: PubMed
    10. Salinger JM, O'Brien MP, Miklowitz DJ, Marvin SE, Cannon T. Family Communication With Teens at Clinical High-Risk for Psychosis or Bipolar Disorder. J Fam Psychol. 2018 Feb 01. PMID: 29389150.
      View in: PubMed
    11. Bronstein MV, Cannon T. Measuring bias against disconfirmatory evidence: An evaluation of BADE task scoring methods and the case for a novel method. Psychiatry Res. 2018 Mar; 261:535-540. PMID: 29407719.
      View in: PubMed
    12. Ryan AT, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon T, Walker EF. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome. Schizophr Res. 2017 Dec 23. PMID: 29279247.
      View in: PubMed
    13. Lam M, Trampush JW, Yu J, Knowles E, Davies G, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, DeRosse P, Lundervold AJ, Steen VM, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Chiba-Falek O, Attix DK, Need AC, Cirulli ET, Voineskos AN, Stefanis NC, Avramopoulos D, Hatzimanolis A, Arking DE, Smyrnis N, Bilder RM, Freimer NA, Cannon T, London E, Poldrack RA, Sabb FW, Congdon E, Conley ED, Scult MA, Dickinson D, Straub RE, Donohoe G, Morris D, Corvin A, Gill M, Hariri AR, Weinberger DR, Pendleton N, Bitsios P, Rujescu D, Lahti J, Le Hellard S, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK, Lencz T. Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets. Cell Rep. 2017 Nov 28; 21(9):2597-2613. PMID: 29186694.
      View in: PubMed
    14. Cannon T, Cao H, Mathalon DH, Forsyth J. Reliability of functional magnetic resonance imaging activation during working memory in a multisite study: Clarification and implications for statistical power. Neuroimage. 2017 Dec; 163:456-458. PMID: 29113944.
      View in: PubMed
    15. Bradshaw NJ, Ukkola-Vuoti L, Pankakoski M, Zheutlin AB, Ortega-Alonso A, Torniainen-Holm M, Sinha V, Therman S, Paunio T, Suvisaari J, Lönnqvist J, Cannon T, Haukka J, Hennah W. The NDE1 genomic locus can affect treatment of psychiatric illness through gene expression changes related to microRNA-484. Open Biol. 2017 Nov; 7(11). PMID: 29142105.
      View in: PubMed
    16. Cannon T, Cao H, Mathalon DH, Gee DG. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study: Clarification and implications for statistical power. Hum Brain Mapp. 2018 Jan; 39(1):599-601. PMID: 29086463.
      View in: PubMed
    17. Stowkowy J, Liu L, Cadenhead KS, Tsuang MT, Cannon T, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J. Exploration of clinical high-risk dropouts. Schizophr Res. 2017 Sep 27. PMID: 28964651.
      View in: PubMed
    18. Bear A, Fortgang RG, Bronstein MV, Cannon T. Mistiming of thought and perception predicts delusionality. Proc Natl Acad Sci U S A. 2017 Oct 03; 114(40):10791-10796. PMID: 28923963.
      View in: PubMed
    19. Lu Y, Marshall C, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Res. 2017 Dec; 258:462-468. PMID: 28886901.
      View in: PubMed
    20. Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry. 2017 Aug 09. PMID: 28792113.
      View in: PubMed
    21. Eckfeld A, Karlsgodt KH, Haut KM, Bachman P, Jalbrzikowski M, Zinberg J, van Erp TGM, Cannon T, Bearden CE. Disrupted Working Memory Circuitry in Adolescent Psychosis. Front Hum Neurosci. 2017; 11:394. PMID: 28848413.
      View in: PubMed
    22. Savill M, D'Ambrosio J, Cannon T, Loewy RL. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review. Early Interv Psychiatry. 2018 Feb; 12(1):3-14. PMID: 28782283.
      View in: PubMed
    23. Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Interv Psychiatry. 2017 Aug 03. PMID: 28771938.
      View in: PubMed
    24. Allswede DM, Zheutlin AB, Chung Y, Anderson K, Hultman CM, Ingvar M, Cannon T. Complement Gene Expression Correlates with Superior Frontal Cortical Thickness in Humans. Neuropsychopharmacology. 2018 Feb; 43(3):525-533. PMID: 28758643.
      View in: PubMed
    25. Lee J, Nuechterlein KH, Knowlton BJ, Bearden CE, Cannon T, Fiske AP, Ghermezi L, Hayata JN, Hellemann GS, Horan WP, Kee K, Kern RS, Subotnik KL, Sugar CA, Ventura J, Yee CM, Green MF. Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia. Schizophr Bull. 2017 Jul 06. PMID: 29106694.
      View in: PubMed
    26. Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon T, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res. 2018 Feb; 192:357-363. PMID: 28578922.
      View in: PubMed
    27. Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon T, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Reichenberg A, Bearden CE. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Dev Psychopathol. 2018 Feb; 30(1):39-47. PMID: 28420458.
      View in: PubMed
    28. Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res. 2017 Dec; 190:90-95. PMID: 28372906.
      View in: PubMed
    29. Chung Y, Haut KM, He G, van Erp TGM, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cannon T. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophr Res. 2017 Nov; 189:169-174. PMID: 28245961.
      View in: PubMed
    30. Zheutlin AB, Jeffries CD, Perkins DO, Chung Y, Chekroud AM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Tsuang M, Cannon T. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology. 2017 Oct; 42(11):2188-2195. PMID: 28186095.
      View in: PubMed
    31. Johansson V, Jakobsson J, Fortgang RG, Zetterberg H, Blennow K, Cannon T, Hultman CM, Wetterberg L, Landén M. Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders. Eur Arch Psychiatry Clin Neurosci. 2017 Aug; 267(5):391-402. PMID: 28039552.
      View in: PubMed
    32. Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon T, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016 Dec 01; 73(12):1239-1248. PMID: 27806157.
      View in: PubMed
    33. Kegel ME, Johansson V, Wetterberg L, Bhat M, Schwieler L, Cannon T, Schuppe-Koistinen I, Engberg G, Landén M, Hultman CM, Erhardt S. Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity. Psychiatry Res. 2017 01; 247:105-112. PMID: 27886578.
      View in: PubMed
    34. Walter A, Suenderhauf C, Harrisberger F, Lenz C, Smieskova R, Chung Y, Cannon T, Bearden CE, Rapp C, Bendfeldt K, Borgwardt S, Vogel T. Hippocampal volume in subjects at clinical high-risk for psychosis: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2016 12; 71:680-690. PMID: 27773693.
      View in: PubMed
    35. Noble S, Scheinost D, Finn ES, Shen X, Papademetris X, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Woods SW, Cannon T, Constable RT. Multisite reliability of MR-based functional connectivity. Neuroimage. 2017 Feb 01; 146:959-970. PMID: 27746386.
      View in: PubMed
    36. Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. J Clin Child Adolesc Psychol. 2018 Jan-Feb; 47(1):69-78. PMID: 27705009.
      View in: PubMed
    37. Cannon T, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Kattan MW. An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry. 2016 Oct 01; 173(10):980-988. PMID: 27363508.
      View in: PubMed
    38. Buchy L, Mathalon DH, Cannon T, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Addington J. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Res Neuroimaging. 2016 Aug 30; 254:3-9. PMID: 27289213.
      View in: PubMed
    39. Marshall C, Deighton S, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Res. 2016 08 30; 242:61-66. PMID: 27259137.
      View in: PubMed
    40. Deighton S, Buchy L, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophr Res. 2016 07; 174(1-3):77-81. PMID: 27165121; PMCID: PMC5037435 [Available on 07/01/17].
    41. McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon T, Heinssen RK, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Goldberg TE, Harvey PD, Cornblatt BA. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophr Bull. 2016 09; 42(5):1234-42. PMID: 27105902; PMCID: PMC4988745 [Available on 09/01/17].
    42. Gifford G, Crossley N, Fusar-Poli P, Schnack HG, Kahn RS, Koutsouleris N, Cannon T, McGuire P. Using neuroimaging to help predict the onset of psychosis. Neuroimage. 2017 Jan 15; 145(Pt B):209-217. PMID: 27039698.
      View in: PubMed
    43. Moskow DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Cannon T, Woods SW, Walker EF. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophr Res. 2016 Apr; 172(1-3):29-34. PMID: 26905038; PMCID: PMC4821739 [Available on 04/01/17].
    44. Allswede DM, Buka SL, Yolken RH, Torrey EF, Cannon T. Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring. Schizophr Res. 2016 Apr; 172(1-3):41-5. PMID: 26897476.
      View in: PubMed
    45. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. PMID: 26896388.
      View in: PubMed
    46. Stowkowy J, Liu L, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol. 2016 Apr; 51(4):497-503. PMID: 26851943.
      View in: PubMed
    47. Cannon T, Moffitt T, Brennan P, Raine A, Baker L. Sarnoff A. Mednick (1928-2015). Am Psychol. 2016 Feb-Mar; 71(2):148. PMID: 26866990.
      View in: PubMed
    48. Chekroud AM, Zotti RJ, Shehzad Z, Gueorguieva R, Johnson MK, Trivedi MH, Cannon T, Krystal JH, Corlett PR. Cross-trial prediction of treatment outcome in depression: a machine learning approach. Lancet Psychiatry. 2016 Mar; 3(3):243-50. PMID: 26803397.
      View in: PubMed
    49. Piskulic D, Liu L, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophr Res. 2016 Mar; 171(1-3):176-81. PMID: 26785807.
      View in: PubMed
    50. Kremen WS, Panizzon MS, Cannon T. Genetics and neuropsychology: A merger whose time has come. Neuropsychology. 2016 Jan; 30(1):1-5. PMID: 26710091; PMCID: PMC4758834.
    51. Zheutlin AB, Viehman RW, Fortgang R, Borg J, Smith DJ, Suvisaari J, Therman S, Hultman CM, Cannon T. Cognitive endophenotypes inform genome-wide expression profiling in schizophrenia. Neuropsychology. 2016 Jan; 30(1):40-52. PMID: 26710095; PMCID: PMC4693618.
    52. Cannon T. Microglial Activation and the Onset of Psychosis. Am J Psychiatry. 2016 Jan; 173(1):3-4. PMID: 26725337.
      View in: PubMed
    53. Cannon T, Widiger T. Introduction. Annu Rev Clin Psychol. 2016; 12:1 p preceding 1. PMID: 27471770.
      View in: PubMed
    54. Cannon T. Deciphering the Genetic Complexity of Schizophrenia. JAMA Psychiatry. 2016 Jan; 73(1):5-6. PMID: 26606598.
      View in: PubMed
    55. Cannon T. Brain Biomarkers of Vulnerability and Progression to Psychosis. Schizophr Bull. 2016 Jul; 42 Suppl 1:S127-32. PMID: 26656880; PMCID: PMC4960430 [Available on 07/01/17].
    56. Buchy L, Seidman LJ, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Res. 2015 Dec 30; 230(3):878-84. PMID: 26626949; PMCID: PMC5037441 [Available on 12/30/16].
    57. Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon T, O'Donovan M, Correll CU, Kane JM, van Os J, Insel TR. Schizophrenia. Nat Rev Dis Primers. 2015 11 12; 1:15067. PMID: 27189524.
      View in: PubMed
    58. Buchy L, Cannon T, Anticevic A, Lyngberg K, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry. 2015 Nov 09; 15:276. PMID: 26553191; PMCID: PMC4640353.
    59. Cannon T. How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis. Trends Cogn Sci. 2015 Dec; 19(12):744-756. PMID: 26493362.
      View in: PubMed
    60. Lindgren M, Manninen M, Kalska H, Mustonen U, Laajasalo T, Moilanen K, Huttunen MO, Cannon T, Therman S, Suvisaari J. Evaluation of verbal list learning as a predictor of psychosis. Early Interv Psychiatry. 2017 04; 11(2):171-176. PMID: 26472539.
      View in: PubMed
    61. McAusland L, Buchy L, Cadenhead KS, Cannon T, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Anxiety in youth at clinical high risk for psychosis. Early Interv Psychiatry. 2017 12; 11(6):480-487. PMID: 26456932.
      View in: PubMed
    62. Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon T, Heinssen R, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res. 2015 Dec; 169(1-3):169-177. PMID: 26441004.
      View in: PubMed
    63. Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon T. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. JAMA Psychiatry. 2015 Sep; 72(9):882-91. PMID: 26267151; PMCID: PMC4892891.
    64. Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Heinssen RK, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH, Woods SW. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. Schizophr Bull. 2015 Sep; 41(5):1066-75. PMID: 26272875.
      View in: PubMed
    65. Haut KM, Karlsgodt KH, Bilder RM, Congdon E, Freimer NB, London ED, Sabb FW, Ventura J, Cannon T. Memory systems in schizophrenia: Modularity is preserved but deficits are generalized. Schizophr Res. 2015 Oct; 168(1-2):223-30. PMID: 26299707; PMCID: PMC4591239 [Available on 10/01/16].
    66. O'Brien MP, Miklowitz DJ, Cannon T. Decreases in perceived maternal criticism predict improvement in subthreshold psychotic symptoms in a randomized trial of family-focused therapy for individuals at clinical high risk for psychosis. J Fam Psychol. 2015 Dec; 29(6):945-51. PMID: 26168262; PMCID: PMC4673032.
    67. Fortgang RG, Hultman CM, Cannon T. Coping Styles in Twins Discordant for Schizophrenia, Bipolar Disorder, and Depression. Clin Psychol Sci. 2016 Mar 01; 4(2):216-228. PMID: 27022508.
      View in: PubMed
    68. Cannon T. Network dysconnectivity: a psychosis-triggering mechanism? Biol Psychiatry. 2015 Jun 01; 77(11):927-8. PMID: 25959565.
      View in: PubMed
    69. Waford RN, MacDonald A, Goines K, Novacek DM, Trotman HD, Elaine F W, Addington J, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Heinssen R, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. Demographic correlates of attenuated positive psychotic symptoms. Schizophr Res. 2015 Aug; 166(1-3):31-6. PMID: 25999040; PMCID: PMC4767147.
    70. Barbato M, Liu L, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophr Res Cogn. 2015 Sep; 2(3):133-139. PMID: 27695675.
      View in: PubMed
    71. Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R, Cannon T. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Mol Neuropsychiatry. 2015 May 01; 1(1):13-22. PMID: 26005673.
      View in: PubMed
    72. Addington J, Liu L, Buchy L, Cadenhead KS, Cannon T, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. J Nerv Ment Dis. 2015 May; 203(5):328-35. PMID: 25919383; PMCID: PMC4417745.
    73. Chung Y, Cannon T. Brain imaging during the transition from psychosis prodrome to schizophrenia. J Nerv Ment Dis. 2015 May; 203(5):336-41. PMID: 25900551; PMCID: PMC4414922.
    74. Stowkowy J, Liu L, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Core Schemas in Youth at Clinical High Risk for Psychosis. Behav Cogn Psychother. 2016 Mar; 44(2):203-13. PMID: 25896713.
      View in: PubMed
    75. Robertson CL, Ishibashi K, Mandelkern MA, Brown AK, Ghahremani DG, Sabb F, Bilder R, Cannon T, Borg J, London ED. Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects. J Neurosci. 2015 Apr 15; 35(15):5990-7. PMID: 25878272; PMCID: PMC4397600.
    76. Gee DG, McEwen SC, Forsyth JK, Haut KM, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Constable T, Cannon T. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Hum Brain Mapp. 2015 Jul; 36(7):2558-79. PMID: 25821147.
      View in: PubMed
    77. Haut KM, van Erp TG, Knowlton B, Bearden CE, Subotnik K, Ventura J, Nuechterlein KH, Cannon T. Contributions of Feature Binding During Encoding and Functional Connectivity of the Medial Temporal Lobe Structures to Episodic Memory Deficits Across the Prodromal and First-Episode Phases of Schizophrenia. Clin Psychol Sci. 2015 Mar; 3(2):159-174. PMID: 25750836.
      View in: PubMed
    78. Lindgren M, Manninen M, Kalska H, Mustonen U, Laajasalo T, Moilanen K, Huttunen MO, Cannon T, Suvisaari J, Therman S. Suicidality, self-harm and psychotic-like symptoms in a general adolescent psychiatric sample. Early Interv Psychiatry. 2017 04; 11(2):113-122. PMID: 25582971.
      View in: PubMed
    79. Cannon T, Widiger T. Introduction. Annu Rev Clin Psychol. 2015; 11. PMID: 25997206.
      View in: PubMed
    80. Jann K, Gee DG, Kilroy E, Schwab S, Smith RX, Cannon T, Wang DJ. Functional connectivity in BOLD and CBF data: similarity and reliability of resting brain networks. Neuroimage. 2015 Feb 01; 106:111-22. PMID: 25463468; PMCID: PMC4285775.
    81. Miklowitz DJ, O'Brien MP, Cannon T. Reply to "Adolescents are like adults (sort of)". J Am Acad Child Adolesc Psychiatry. 2014 Dec; 53(12):1338. PMID: 25457932.
      View in: PubMed
    82. Trotman HD, Holtzman CW, Walker EF, Addington JM, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Heinssen RK, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res. 2014 Dec; 160(1-3):104-9. PMID: 25443665.
      View in: PubMed
    83. Higier RG, Jimenez AM, Hultman CM, Borg J, Roman C, Kizling I, Larsson H, Cannon T. Enhanced neurocognitive functioning and positive temperament in twins discordant for bipolar disorder. Am J Psychiatry. 2014 Nov 01; 171(11):1191-8. PMID: 25124743.
      View in: PubMed
    84. Severance EG, Gressitt KL, Buka SL, Cannon T, Yolken RH. Maternal complement C1q and increased odds for psychosis in adult offspring. Schizophr Res. 2014 Oct; 159(1):14-9. PMID: 25195065; PMCID: PMC4177507.
    85. Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull. 2015 Mar; 41(2):419-28. PMID: 25103207.
      View in: PubMed
    86. Therman S, Lindgren M, Manninen M, Loewy RL, Huttunen MO, Cannon T, Suvisaari J. Predicting psychosis and psychiatric hospital care among adolescent psychiatric patients with the Prodromal Questionnaire. Schizophr Res. 2014 Sep; 158(1-3):7-10. PMID: 25062972.
      View in: PubMed
    87. Lindgren M, Manninen M, Kalska H, Mustonen U, Laajasalo T, Moilanen K, Huttunen M, Cannon T, Suvisaari J, Therman S. Predicting psychosis in a general adolescent psychiatric sample. Schizophr Res. 2014 Sep; 158(1-3):1-6. PMID: 25015028.
      View in: PubMed
    88. Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon T, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH. Current status specifiers for patients at clinical high risk for psychosis. Schizophr Res. 2014 Sep; 158(1-3):69-75. PMID: 25012147; PMCID: PMC4152558.
    89. Marshall C, Denny E, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker E, Addington J. The content of attenuated psychotic symptoms in those at clinical high risk for psychosis. Psychiatry Res. 2014 Nov 30; 219(3):506-12. PMID: 25048759.
      View in: PubMed
    90. Cannon T, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015 Jan 15; 77(2):147-57. PMID: 25034946; PMCID: PMC4264996.
    91. Miklowitz DJ, O'Brien MP, Schlosser DA, Addington J, Candan KA, Marshall C, Domingues I, Walsh BC, Zinberg JL, De Silva SD, Friedman-Yakoobian M, Cannon T. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. J Am Acad Child Adolesc Psychiatry. 2014 Aug; 53(8):848-58. PMID: 25062592; PMCID: PMC4112074.
    92. Golembo-Smith S, Bachman P, Senturk D, Cannon T, Bearden CE. Youth-caregiver agreement on clinical high-risk symptoms of psychosis. J Abnorm Child Psychol. 2014 May; 42(4):649-58. PMID: 24092494; PMCID: PMC4074879.
    93. Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos HW, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon T. Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage. 2014 Aug 15; 97:41-52. PMID: 24736173.
      View in: PubMed
    94. Marvin SE, Miklowitz DJ, O'Brien MP, Cannon T. Family-focused therapy for individuals at clinical high risk for psychosis: treatment fidelity within a multisite randomized trial. Early Interv Psychiatry. 2016 Apr; 10(2):137-43. PMID: 24725329; PMCID: PMC4194178.
    95. Cannon T. Neurocognitive growth charts and psychosis: is the relationship predictive? JAMA Psychiatry. 2014 Apr; 71(4):361-2. PMID: 24499862.
      View in: PubMed
    96. Tsai KH, López S, Marvin S, Zinberg J, Cannon T, O'Brien M, Bearden CE. Perceptions of family criticism and warmth and their link to symptom expression in racially/ethnically diverse adolescents and young adults at clinical high risk for psychosis. Early Interv Psychiatry. 2015 Dec; 9(6):476-86. PMID: 24576106; PMCID: PMC4146748.
    97. Alderman T, Addington J, Bearden C, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Interv Psychiatry. 2015 Dec; 9(6):467-75. PMID: 24576057.
      View in: PubMed
    98. Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon T, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull. 2014 Nov; 40(6):1452-61. PMID: 24550526.
      View in: PubMed
    99. Congdon E, Altshuler LL, Mumford JA, Karlsgodt KH, Sabb FW, Ventura J, McGough JJ, London ED, Cannon T, Bilder RM, Poldrack RA. Neural activation during response inhibition in adult attention-deficit/hyperactivity disorder: preliminary findings on the effects of medication and symptom severity. Psychiatry Res. 2014 Apr 30; 222(1-2):17-28. PMID: 24581734; PMCID: PMC4009011.
    100. Helfinstein SM, Schonberg T, Congdon E, Karlsgodt KH, Mumford JA, Sabb FW, Cannon T, London ED, Bilder RM, Poldrack RA. Predicting risky choices from brain activity patterns. Proc Natl Acad Sci U S A. 2014 Feb 18; 111(7):2470-5. PMID: 24550270; PMCID: PMC3932884.
    101. White CN, Congdon E, Mumford JA, Karlsgodt KH, Sabb FW, Freimer NB, London ED, Cannon T, Bilder RM, Poldrack RA. Decomposing decision components in the stop-signal task: a model-based approach to individual differences in inhibitory control. J Cogn Neurosci. 2014 Aug; 26(8):1601-14. PMID: 24405185; PMCID: PMC4119005.
    102. Glen WB, Horowitz B, Carlson GC, Cannon T, Talbot K, Jentsch JD, Lavin A. Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning. Hippocampus. 2014 Feb; 24(2):204-13. PMID: 24446171; PMCID: PMC3937842.
    103. O'Brien MP, Miklowitz DJ, Candan KA, Marshall C, Domingues I, Walsh BC, Zinberg JL, De Silva SD, Woodberry KA, Cannon T. A randomized trial of family focused therapy with populations at clinical high risk for psychosis: effects on interactional behavior. J Consult Clin Psychol. 2014 Feb; 82(1):90-101. PMID: 24188511; PMCID: PMC3909734.
    104. Tarbox SI, Addington J, Cadenhead KS, Cannon T, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol. 2013 Nov; 25(4 Pt 1):1171-86. PMID: 24229556.
      View in: PubMed
    105. Jalbrzikowski M, Krasileva KE, Marvin S, Zinberg J, Andaya A, Bachman P, Cannon T, Bearden CE. Reciprocal social behavior in youths with psychotic illness and those at clinical high risk. Dev Psychopathol. 2013 Nov; 25(4 Pt 1):1187-97. PMID: 24229557; PMCID: PMC4416482.
    106. Karlsgodt KH, van Erp TG, Bearden CE, Cannon T. Altered relationships between age and functional brain activation in adolescents at clinical high risk for psychosis. Psychiatry Res. 2014 Jan 30; 221(1):21-9. PMID: 24144510; PMCID: PMC3921908.
    107. Tarbox SI, Addington J, Cadenhead KS, Cannon T, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Res. 2014 Jan 30; 215(1):52-60. PMID: 24200216.
      View in: PubMed
    108. Congdon E, Bato AA, Schonberg T, Mumford JA, Karlsgodt KH, Sabb FW, London ED, Cannon T, Bilder RM, Poldrack RA. Differences in neural activation as a function of risk-taking task parameters. Front Neurosci. 2013; 7:173. PMID: 24137106; PMCID: PMC3786224.
    109. Cannon T, Sun F, McEwen SJ, Papademetris X, He G, van Erp TG, Jacobson A, Bearden CE, Walker E, Hu X, Zhou L, Seidman LJ, Thermenos HW, Cornblatt B, Olvet DM, Perkins D, Belger A, Cadenhead K, Tsuang M, Mirzakhanian H, Addington J, Frayne R, Woods SW, McGlashan TH, Constable RT, Qiu M, Mathalon DH, Thompson P, Toga AW. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Hum Brain Mapp. 2014 May; 35(5):2424-34. PMID: 23982962.
      View in: PubMed
    110. Cadenhead KS, Addington J, Cannon T, Cornblatt BA, de la Fuente-Sandoval C, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, Duncan E, Johannesen J, León-Ortiz P, Light G, Mondragón A, Niznikiewicz M, Nunag J, Roach BJ, Solís-Vivanco R. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 2013 Aug 07; 24(11):626-30. PMID: 23799460; PMCID: PMC4135529.
    111. Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon T, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res. 2013 Aug; 148(1-3):99-104. PMID: 23787224; PMCID: PMC3867209.
    112. Saleem MM, Stowkowy J, Cadenhead KS, Cannon T, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington J. Perceived discrimination in those at clinical high risk for psychosis. Early Interv Psychiatry. 2014 Feb; 8(1):77-81. PMID: 23773288.
      View in: PubMed
    113. Thakkar KN, Congdon E, Poldrack RA, Sabb FW, London ED, Cannon T, Bilder RM. Women are more sensitive than men to prior trial events on the Stop-signal task. Br J Psychol. 2014 May; 105(2):254-72. PMID: 24754812; PMCID: PMC4000536.
    114. Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Cannon T, McGlashan TH, Woods SW. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry. 2013 Sep 15; 74(6):410-7. PMID: 23562006.
      View in: PubMed
    115. Bloom RJ, Kähler AK, Collins AL, Chen G, Cannon T, Hultman C, Sullivan PF. Comprehensive analysis of copy number variation in monozygotic twins discordant for bipolar disorder or schizophrenia. Schizophr Res. 2013 May; 146(1-3):289-90. PMID: 23507357; PMCID: PMC3650833.
    116. Saggu S, Cannon T, Jentsch JD, Lavin A. Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice. Schizophr Res. 2013 May; 146(1-3):254-63. PMID: 23473812; PMCID: PMC3628687.
    117. Addington J, Stowkowy J, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon T. Early traumatic experiences in those at clinical high risk for psychosis. Early Interv Psychiatry. 2013 Aug; 7(3):300-5. PMID: 23343384.
      View in: PubMed
    118. Walder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon T, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EF. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophr Res. 2013 Mar; 144(1-3):43-50. PMID: 23340377; PMCID: PMC4045468.
    119. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013 Jan; 70(1):107-20. PMID: 23165428; PMCID: PMC4356506.
    120. Moran ZD, Bachman P, Pham P, Cho SH, Cannon T, Shams L. Multisensory encoding improves auditory recognition. Multisens Res. 2013; 26(6):581-92. PMID: 24800415.
      View in: PubMed
    121. Jalbrzikowski M, Sugar CA, Zinberg J, Bachman P, Cannon T, Bearden CE. Coping styles of individuals at clinical high risk for developing psychosis. Early Interv Psychiatry. 2014 Feb; 8(1):68-76. PMID: 23164368; PMCID: PMC3582773.
    122. Falkai P, Malchow B, Wobrock T, Gruber O, Schmitt A, Honer WG, Pajonk FG, Sun F, Cannon T. The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study. Eur Arch Psychiatry Clin Neurosci. 2013 Sep; 263(6):469-73. PMID: 23161338.
      View in: PubMed
    123. Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon T, de Haan L, French P, Fusar-Poli P, Keshavan M, Klosterkötter J, Kwon JS, McGorry PD, McGuire P, Mizuno M, Morrison AP, Riecher-Rössler A, Salokangas RK, Seidman LJ, Suzuki M, Valmaggia L, van der Gaag M, Wood SJ, McGlashan TH. Whither the attenuated psychosis syndrome? Schizophr Bull. 2012 Nov; 38(6):1130-4. PMID: 23144056; PMCID: PMC3494060.
    124. Jalbrzikowski M, Carter C, Senturk D, Chow C, Hopkins JM, Green MF, Galván A, Cannon T, Bearden CE. Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis? Schizophr Res. 2012 Dec; 142(1-3):99-107. PMID: 23122739; PMCID: PMC3714207.
    125. Karlsgodt KH, Rosser T, Lutkenhoff ES, Cannon T, Silva A, Bearden CE. Alterations in white matter microstructure in neurofibromatosis-1. PLoS One. 2012; 7(10):e47854. PMID: 23094098; PMCID: PMC3477133.
    126. Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon T. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012 Dec; 142(1-3):77-82. PMID: 23043872.
      View in: PubMed
    127. Johansson V, Nybom R, Wetterberg L, Hultman CM, Cannon T, Johansson AG, Ekman CJ, Landén M. Microscopic particles in two fractions of fresh cerebrospinal fluid in twins with schizophrenia or bipolar disorder and in healthy controls. PLoS One. 2012; 7(9):e45994. PMID: 23049916; PMCID: PMC3457946.
    128. Fineberg AM, Ellman LM, Buka S, Yolken R, Cannon T. Decreased birth weight in psychosis: influence of prenatal exposure to serologically determined influenza and hypoxia. Schizophr Bull. 2013 Sep; 39(5):1037-44. PMID: 22966148; PMCID: PMC3756769.
    129. Forsyth JK, Ellman LM, Tanskanen A, Mustonen U, Huttunen MO, Suvisaari J, Cannon T. Genetic risk for schizophrenia, obstetric complications, and adolescent school outcome: evidence for gene-environment interaction. Schizophr Bull. 2013 Sep; 39(5):1067-76. PMID: 22941745; PMCID: PMC3756777.
    130. Lutkenhoff E, Karlsgodt KH, Gutman B, Stein JL, Thompson PM, Cannon T, Jentsch JD. Structural and functional neuroimaging phenotypes in dysbindin mutant mice. Neuroimage. 2012 Aug 01; 62(1):120-9. PMID: 22584233.
      View in: PubMed
    131. Bachman P, Niendam TA, Jalbrzikowski M, Jalbrzikowkski M, Park CY, Daley M, Cannon T, Bearden CE. Processing speed and neurodevelopment in adolescent-onset psychosis: cognitive slowing predicts social function. J Abnorm Child Psychol. 2012 May; 40(4):645-54. PMID: 22134489; PMCID: PMC4119229.
    132. Cannon T. Community reforms to reduce severity, chronicity, and disability of psychosis: do they work? Am J Psychiatry. 2012 Apr; 169(4):345-7. PMID: 22476671.
      View in: PubMed
    133. Piskulic D, Addington J, Cadenhead KS, Cannon T, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012 Apr 30; 196(2-3):220-4. PMID: 22445704.
      View in: PubMed
    134. van Haren NE, Rijsdijk F, Schnack HG, Picchioni MM, Toulopoulou T, Weisbrod M, Sauer H, van Erp TG, Cannon T, Huttunen MO, Boomsma DI, Hulshoff Pol HE, Murray RM, Kahn RS. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biol Psychiatry. 2012 May 15; 71(10):915-21. PMID: 22341827; PMCID: PMC3343260.
    135. Orešic M, Seppänen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyötyläinen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lönnqvist J, Cannon T. Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18; 4(1):1. PMID: 22257447; PMCID: PMC3334549.
    136. Schlosser DA, Miklowitz DJ, O'Brien MP, De Silva SD, Zinberg JL, Cannon T. A randomized trial of family focused treatment for adolescents and young adults at risk for psychosis: study rationale, design and methods. Early Interv Psychiatry. 2012 Aug; 6(3):283-91. PMID: 22182667; PMCID: PMC4106700.
    137. Gee DG, Karlsgodt KH, van Erp TG, Bearden CE, Lieberman MD, Belger A, Perkins DO, Olvet DM, Cornblatt BA, Constable T, Woods SW, Addington J, Cadenhead KS, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Cannon T. Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophr Res. 2012 Jan; 134(1):1-9. PMID: 22056201.
      View in: PubMed
    138. Gee DG, Cannon T. Prediction of conversion to psychosis: review and future directions. Rev Bras Psiquiatr. 2011 Oct; 33 Suppl 2:s129-42. PMID: 22286564; PMCID: PMC4098037.
    139. Loewy RL, Therman S, Manninen M, Huttunen MO, Cannon T. Prodromal psychosis screening in adolescent psychiatry clinics. Early Interv Psychiatry. 2012 Feb; 6(1):69-75. PMID: 21883972.
      View in: PubMed
    140. Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, Bearden CE, Cannon T. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull. 2012 Nov; 38(6):1225-33. PMID: 21825282; PMCID: PMC3494042.
    141. Bearden CE, Wu KN, Caplan R, Cannon T. Thought disorder and communication deviance as predictors of outcome in youth at clinical high risk for psychosis. J Am Acad Child Adolesc Psychiatry. 2011 Jul; 50(7):669-80. PMID: 21703494; PMCID: PMC3124656.
    142. Mittal VA, Jalbrzikowski M, Daley M, Roman C, Bearden CE, Cannon T. Abnormal movements are associated with poor psychosocial functioning in adolescents at high risk for psychosis. Schizophr Res. 2011 Aug; 130(1-3):164-9. PMID: 21636252; PMCID: PMC3139832.
    143. Loewy RL, Pearson R, Vinogradov S, Bearden CE, Cannon T. Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B). Schizophr Res. 2011 Jun; 129(1):42-6. PMID: 21511440; PMCID: PMC3113633.
    144. Addington J, Cornblatt BA, Cadenhead KS, Cannon T, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011 Aug; 168(8):800-5. PMID: 21498462.
      View in: PubMed
    145. van Erp TG, Thompson PM, Kieseppä T, Bearden CE, Marino AC, Hoftman GD, Haukka J, Partonen T, Huttunen M, Kaprio J, Lönnqvist J, Poutanen VP, Toga AW, Cannon T. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins. Hum Brain Mapp. 2012 Mar; 33(3):501-10. PMID: 21455943; PMCID: PMC4383766.
    146. Bearden CE, van Erp TG, Dutton RA, Boyle C, Madsen S, Luders E, Kieseppa T, Tuulio-Henriksson A, Huttunen M, Partonen T, Kaprio J, Lönnqvist J, Thompson PM, Cannon T. Mapping corpus callosum morphology in twin pairs discordant for bipolar disorder. Cereb Cortex. 2011 Oct; 21(10):2415-24. PMID: 21383237; PMCID: PMC3169664.
    147. Green MF, Bearden CE, Cannon T, Fiske AP, Hellemann GS, Horan WP, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Yee CM, Nuechterlein KH. Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophr Bull. 2012 Jun; 38(4):854-64. PMID: 21345917; PMCID: PMC3406534.
    148. Cannon T. Objective tests for schizophrenia: window to the future. World Psychiatry. 2011 Feb; 10(1):36-7. PMID: 21379352; PMCID: PMC3048503.
    149. Karlsgodt KH, Robleto K, Trantham-Davidson H, Jairl C, Cannon T, Lavin A, Jentsch JD. Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry. 2011 Jan 01; 69(1):28-34. PMID: 21035792; PMCID: PMC4204919.
    150. Mittal VA, Karlsgodt K, Zinberg J, Cannon T, Bearden CE. Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms. Am J Psychiatry. 2010 Sep; 167(9):1033-7. PMID: 20826854; PMCID: PMC4414088.
    151. Lindgren M, Manninen M, Laajasalo T, Mustonen U, Kalska H, Suvisaari J, Moilanen K, Cannon T, Huttunen M, Therman S. The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample. Schizophr Res. 2010 Oct; 123(1):77-85. PMID: 20729039.
      View in: PubMed
    152. Mittal VA, Daley M, Shiode MF, Bearden CE, O'Neill J, Cannon T. Striatal volumes and dyskinetic movements in youth at high-risk for psychosis. Schizophr Res. 2010 Oct; 123(1):68-70. PMID: 20732793; PMCID: PMC2939316.
    153. Cadenhead KS, Addington J, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Heinssen R. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Interv Psychiatry. 2010 Aug; 4(3):220-6. PMID: 20712727.
      View in: PubMed
    154. Karlsgodt KH, Sun D, Cannon T. Structural and Functional Brain Abnormalities in Schizophrenia. Curr Dir Psychol Sci. 2010 Aug; 19(4):226-231. PMID: 25414548.
      View in: PubMed
    155. Shilyansky C, Karlsgodt KH, Cummings DM, Sidiropoulou K, Hardt M, James AS, Ehninger D, Bearden CE, Poirazi P, Jentsch JD, Cannon T, Levine MS, Silva AJ. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A. 2010 Jul 20; 107(29):13141-6. PMID: 20624961; PMCID: PMC2919968.
    156. Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon T, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010 Jun; 67(6):578-88. PMID: 20530007.
      View in: PubMed
    157. Schnack HG, van Haren NE, Brouwer RM, van Baal GC, Picchioni M, Weisbrod M, Sauer H, Cannon T, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Hulshoff Pol HE. Mapping reliability in multicenter MRI: voxel-based morphometry and cortical thickness. Hum Brain Mapp. 2010 Dec; 31(12):1967-82. PMID: 21086550.
      View in: PubMed
    158. Cannon T. Candidate gene studies in the GWAS era: the MET proto-oncogene, neurocognition, and schizophrenia. Am J Psychiatry. 2010 Apr; 167(4):369-72. PMID: 20360324.
      View in: PubMed
    159. Mittal VA, Walker EF, Bearden CE, Walder D, Trottman H, Daley M, Simone A, Cannon T. Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period. Biol Psychiatry. 2010 Jul 01; 68(1):93-9. PMID: 20227679; PMCID: PMC2891189.
    160. Schlosser DA, Zinberg JL, Loewy RL, Casey-Cannon S, O'Brien MP, Bearden CE, Vinogradov S, Cannon T. Predicting the longitudinal effects of the family environment on prodromal symptoms and functioning in patients at-risk for psychosis. Schizophr Res. 2010 May; 118(1-3):69-75. PMID: 20171848; PMCID: PMC2856759.
    161. Yee CM, Mathis KI, Sun JC, Sholty GL, Lang PJ, Bachman P, Williams TJ, Bearden CE, Cannon T, Green MF, Subotnik KL, Ventura J, Nuechterlein KH. Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia. J Abnorm Psychol. 2010 Feb; 119(1):71-82. PMID: 20141244; PMCID: PMC2853376.
    162. Sabb FW, van Erp TG, Hardt ME, Dapretto M, Caplan R, Cannon T, Bearden CE. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis. Schizophr Res. 2010 Feb; 116(2-3):173-83. PMID: 19861234; PMCID: PMC2818263.
    163. Bachman P, Kim J, Yee CM, Therman S, Manninen M, Lönnqvist J, Kaprio J, Huttunen MO, Näätänen R, Cannon T. Efficiency of working memory encoding in twins discordant for schizophrenia. Psychiatry Res. 2009 Nov 30; 174(2):97-104. PMID: 19853415; PMCID: PMC2792637.
    164. Sun D, van Erp TG, Thompson PM, Bearden CE, Daley M, Kushan L, Hardt ME, Nuechterlein KH, Toga AW, Cannon T. Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biol Psychiatry. 2009 Dec 01; 66(11):1055-60. PMID: 19729150; PMCID: PMC3192809.
    165. Therman S, Suvisaari JM, Kalska H, Huttunen MO, Manninen M, Cannon T. Lack of association between neuropsychological performance and level of psychosis-proneness in an adolescent psychiatric sample. J Nerv Ment Dis. 2009 Sep; 197(9):669-74. PMID: 19752646.
      View in: PubMed
    166. Walker EF, Cornblatt BA, Addington J, Cadenhead KS, Cannon T, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Heinssen R. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res. 2009 Nov; 115(1):50-7. PMID: 19709859.
      View in: PubMed
    167. Sanz JH, Karlsgodt KH, Bearden CE, van Erp TG, Nandy RR, Ventura J, Nuechterlein K, Cannon T. Symptomatic and functional correlates of regional brain physiology during working memory processing in patients with recent onset schizophrenia. Psychiatry Res. 2009 Sep 30; 173(3):177-82. PMID: 19692211; PMCID: PMC2734873.
    168. Torrey EF, Buka S, Cannon T, Goldstein JM, Seidman LJ, Liu T, Hadley T, Rosso IM, Bearden C, Yolken RH. Paternal age as a risk factor for schizophrenia: how important is it? Schizophr Res. 2009 Oct; 114(1-3):1-5. PMID: 19683417.
      View in: PubMed
    169. Mittal VA, Willhite R, Daley M, Bearden CE, Niendam T, Ellman LM, Cannon T. Obstetric complications and risk for conversion to psychosis among individuals at high clinical risk. Early Interv Psychiatry. 2009 Aug; 3(3):226-30. PMID: 22640387; PMCID: PMC4090059.
    170. Jentsch JD, Trantham-Davidson H, Jairl C, Tinsley M, Cannon T, Lavin A. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. Neuropsychopharmacology. 2009 Nov; 34(12):2601-8. PMID: 19641486; PMCID: PMC2762021.
    171. Xiao J, Buka SL, Cannon T, Suzuki Y, Viscidi RP, Torrey EF, Yolken RH. Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect. 2009 Nov; 11(13):1011-8. PMID: 19638313.
      View in: PubMed
    172. Pietiläinen OP, Paunio T, Loukola A, Tuulio-Henriksson A, Kieseppä T, Thompson P, Toga AW, van Erp TG, Silventoinen K, Soronen P, Hennah W, Turunen JA, Wedenoja J, Palo OM, Silander K, Lönnqvist J, Kaprio J, Cannon T, Peltonen L. Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins. Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 05; 150B(5):683-92. PMID: 19051289.
      View in: PubMed
    173. Cho S, Moody TD, Fernandino L, Mumford JA, Poldrack RA, Cannon T, Knowlton BJ, Holyoak KJ. Common and dissociable prefrontal loci associated with component mechanisms of analogical reasoning. Cereb Cortex. 2010 Mar; 20(3):524-33. PMID: 19549622.
      View in: PubMed
    174. Karlsgodt KH, Niendam TA, Bearden CE, Cannon T. White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis. Biol Psychiatry. 2009 Sep 15; 66(6):562-9. PMID: 19423081; PMCID: PMC2805703.
    175. Woods SW, Addington J, Cadenhead KS, Cannon T, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009 Sep; 35(5):894-908. PMID: 19386578.
      View in: PubMed
    176. Cannon T. What is the role of theories in the study of schizophrenia? Schizophr Bull. 2009 May; 35(3):563-7. PMID: 19336393; PMCID: PMC2669583.
    177. Ellman LM, Yolken RH, Buka SL, Torrey EF, Cannon T. Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol Psychiatry. 2009 Jun 15; 65(12):1040-7. PMID: 19195645; PMCID: PMC4058882.
    178. Karlsgodt KH, Sanz J, van Erp TG, Bearden CE, Nuechterlein KH, Cannon T. Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia. Schizophr Res. 2009 Mar; 108(1-3):143-50. PMID: 19196494; PMCID: PMC2671001.
    179. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon T, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009 Jan 17; 373(9659):234-9. PMID: 19150704; PMCID: PMC3879718.
    180. Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, van Erp TG, Thompson PM, Toga AW, Cannon T, Pantelis C. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res. 2009 Mar; 108(1-3):85-92. PMID: 19138834; PMCID: PMC2670732.
    181. Niendam TA, Berzak J, Cannon T, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res. 2009 Mar; 108(1-3):170-5. PMID: 19097751; PMCID: PMC2670932.
    182. O'Brien MP, Zinberg JL, Ho L, Rudd A, Kopelowicz A, Daley M, Bearden CE, Cannon T. Family problem solving interactions and 6-month symptomatic and functional outcomes in youth at ultra-high risk for psychosis and with recent onset psychotic symptoms: a longitudinal study. Schizophr Res. 2009 Feb; 107(2-3):198-205. PMID: 18996681; PMCID: PMC2737734.
    183. Cannon T. Neurodevelopment and the transition from schizophrenia prodrome to schizophrenia: research imperatives. Biol Psychiatry. 2008 Nov 01; 64(9):737-8. PMID: 18929728.
      View in: PubMed
    184. O'Brien MP, Zinberg JL, Bearden CE, Lopez SR, Kopelowicz A, Daley M, Cannon T. Parent attitudes and parent adolescent interaction in families of youth at risk for psychosis and with recent-onset psychotic symptoms. Early Interv Psychiatry. 2008 Nov; 2(4):268-76. PMID: 21352160.
      View in: PubMed
    185. Friedman L, Stern H, Brown GG, Mathalon DH, Turner J, Glover GH, Gollub RL, Lauriello J, Lim KO, Cannon T, Greve DN, Bockholt HJ, Belger A, Mueller B, Doty MJ, He J, Wells W, Smyth P, Pieper S, Kim S, Kubicki M, Vangel M, Potkin SG. Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp. 2008 Aug; 29(8):958-72. PMID: 17636563; PMCID: PMC3670112.
    186. Mittal VA, Ellman LM, Cannon T. Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull. 2008 Nov; 34(6):1083-94. PMID: 18635675; PMCID: PMC2632505.
    187. Willhite RK, Niendam TA, Bearden CE, Zinberg J, O'Brien MP, Cannon T. Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder. Schizophr Res. 2008 Sep; 104(1-3):237-45. PMID: 18573639; PMCID: PMC2612126.
    188. Bachman P, Kim J, Yee CM, Therman S, Manninen M, Lönnqvist J, Kaprio J, Huttunen MO, Näätänen R, Cannon T. Abnormally high EEG alpha synchrony during working memory maintenance in twins discordant for schizophrenia. Schizophr Res. 2008 Aug; 103(1-3):293-7. PMID: 18534822; PMCID: PMC2583438.
    189. Cannon T, Yolken R, Buka S, Torrey EF. Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia. Biol Psychiatry. 2008 Nov 01; 64(9):797-802. PMID: 18486103; PMCID: PMC2655104.
    190. Bearden CE, van Erp TG, Dutton RA, Lee AD, Simon TJ, Cannon T, Emanuel BS, McDonald-McGinn D, Zackai EH, Thompson PM. Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions. Cereb Cortex. 2009 Jan; 19(1):115-26. PMID: 18483006; PMCID: PMC2733329.
    191. van Erp TG, Therman S, Pirkola T, Tuulio-Henriksson A, Glahn DC, Bachman P, Huttunen MO, Lönnqvist J, Hietanen M, Kaprio J, Koskenvuo M, Cannon T. Verbal recall and recognition in twins discordant for schizophrenia. Psychiatry Res. 2008 Jun 30; 159(3):271-80. PMID: 18442861; PMCID: PMC2519867.
    192. Bearden CE, Glahn DC, Lee AD, Chiang MC, van Erp TG, Cannon T, Reiss AL, Toga AW, Thompson PM. Neural phenotypes of common and rare genetic variants. Biol Psychol. 2008 Sep; 79(1):43-57. PMID: 18395317; PMCID: PMC2535822.
    193. Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, van Erp TG, Thompson PM, Toga AW, Cannon T, Pantelis C. WITHDRAWN: Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res. 2008 Feb 11. PMID: 18262769.
      View in: PubMed
    194. Karlsgodt KH, Sun D, Jimenez AM, Lutkenhoff ES, Willhite R, van Erp TG, Cannon T. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol. 2008; 20(4):1297-327. PMID: 18838043.
      View in: PubMed
    195. Cannon T, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008 Jan; 65(1):28-37. PMID: 18180426.
      View in: PubMed
    196. Buka SL, Cannon T, Torrey EF, Yolken RH. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry. 2008 Apr 15; 63(8):809-15. PMID: 17981263.
      View in: PubMed
    197. Li W, Zhou Y, Jentsch JD, Brown RA, Tian X, Ehninger D, Hennah W, Peltonen L, Lönnqvist J, Huttunen MO, Kaprio J, Trachtenberg JT, Silva AJ, Cannon T. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A. 2007 Nov 13; 104(46):18280-5. PMID: 17984054; PMCID: PMC2084334.
    198. O'Brien MP, Zinberg JL, Bearden CE, Daley M, Niendam TA, Kopelowicz A, Cannon T. Psychoeducational multi-family group treatment with adolescents at high risk for developing psychosis. Early Interv Psychiatry. 2007 Nov; 1(4):325-32. PMID: 21352120.
      View in: PubMed
    199. van Erp TG, Lesh TA, Knowlton BJ, Bearden CE, Hardt M, Karlsgodt KH, Shirinyan D, Rao V, Green MF, Subotnik KL, Nuechterlein K, Cannon T. Remember and know judgments during recognition in chronic schizophrenia. Schizophr Res. 2008 Mar; 100(1-3):181-90. PMID: 17964760; PMCID: PMC2517628.
    200. Mittal VA, Cannon T, Willhite R. Floaters: a potential confound in the assessment of perceptual abnormalities. Schizophr Res. 2008 Sep; 104(1-3):305-6. PMID: 17964759.
      View in: PubMed
    201. Cho S, Holyoak KJ, Cannon T. Analogical reasoning in working memory: resources shared among relational integration, interference resolution, and maintenance. Mem Cognit. 2007 Sep; 35(6):1445-55. PMID: 18035640.
      View in: PubMed
    202. Karlsgodt KH, van Erp TG, Poldrack RA, Bearden CE, Nuechterlein KH, Cannon T. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biol Psychiatry. 2008 Mar 01; 63(5):512-8. PMID: 17720147.
      View in: PubMed
    203. Schürmann M, Järveläinen J, Avikainen S, Cannon T, Lönnqvist J, Huttunen M, Hari R. Manifest disease and motor cortex reactivity in twins discordant for schizophrenia. Br J Psychiatry. 2007 Aug; 191:178-9. PMID: 17666504.
      View in: PubMed
    204. Bearden CE, van Erp TG, Thompson PM, Toga AW, Cannon T. Cortical mapping of genotype-phenotype relationships in schizophrenia. Hum Brain Mapp. 2007 Jun; 28(6):519-32. PMID: 17437284; PMCID: PMC3184848.
    205. McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, Penn D, Perkins D, Salokangas RK, Walsh B, Woods SW, Yung A. Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophr Bull. 2007 May; 33(3):715-26. PMID: 17483100; PMCID: PMC2526155.
    206. Ellman LM, Huttunen M, Lönnqvist J, Cannon T. The effects of genetic liability for schizophrenia and maternal smoking during pregnancy on obstetric complications. Schizophr Res. 2007 Jul; 93(1-3):229-36. PMID: 17475446.
      View in: PubMed
    207. Niendam TA, Horwitz J, Bearden CE, Cannon T. Ecological assessment of executive dysfunction in the psychosis prodrome: a pilot study. Schizophr Res. 2007 Jul; 93(1-3):350-4. PMID: 17467957; PMCID: PMC2045154.
    208. Cannon T, Cornblatt B, McGorry P. The empirical status of the ultra high-risk (prodromal) research paradigm. Schizophr Bull. 2007 May; 33(3):661-4. PMID: 17470445; PMCID: PMC2526144.
    209. Loewy RL, Johnson JK, Cannon T. Self-report of attenuated psychotic experiences in a college population. Schizophr Res. 2007 Jul; 93(1-3):144-51. PMID: 17459662; PMCID: PMC2063995.
    210. Cornblatt BA, Auther AM, Niendam T, Smith CW, Zinberg J, Bearden CE, Cannon T. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull. 2007 May; 33(3):688-702. PMID: 17440198; PMCID: PMC2526147.
    211. Niendam TA, Bearden CE, Zinberg J, Johnson JK, O'Brien M, Cannon T. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull. 2007 May; 33(3):772-81. PMID: 17420177; PMCID: PMC2526130.
    212. Addington J, Cadenhead KS, Cannon T, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007 May; 33(3):665-72. PMID: 17255119.
      View in: PubMed
    213. Bearden CE, van Erp TG, Dutton RA, Tran H, Zimmermann L, Sun D, Geaga JA, Simon TJ, Glahn DC, Cannon T, Emanuel BS, Toga AW, Thompson PM. Mapping cortical thickness in children with 22q11.2 deletions. Cereb Cortex. 2007 Aug; 17(8):1889-98. PMID: 17056649; PMCID: PMC2819929.
    214. Karlsgodt KH, Glahn DC, van Erp TG, Therman S, Huttunen M, Manninen M, Kaprio J, Cohen MS, Lönnqvist J, Cannon T. The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res. 2007 Jan; 89(1-3):191-7. PMID: 17029749.
      View in: PubMed
    215. Hirvonen J, van Erp TG, Huttunen J, Aalto S, Någren K, Huttunen M, Lönnqvist J, Kaprio J, Cannon T, Hietala J. Brain dopamine d1 receptors in twins discordant for schizophrenia. Am J Psychiatry. 2006 Oct; 163(10):1747-53. PMID: 17012685.
      View in: PubMed
    216. Ahveninen J, Jääskeläinen IP, Osipova D, Huttunen MO, Ilmoniemi RJ, Kaprio J, Lönnqvist J, Manninen M, Pakarinen S, Therman S, Näätänen R, Cannon T. Inherited auditory-cortical dysfunction in twin pairs discordant for schizophrenia. Biol Psychiatry. 2006 Sep 15; 60(6):612-20. PMID: 16876141.
      View in: PubMed
    217. Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, O'Brien M, Nuechterlein KH, Green MF, Cannon T. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res. 2006 May; 84(1):100-11. PMID: 16563699.
      View in: PubMed
    218. Cannon T, Thompson PM, van Erp TG, Huttunen M, Lonnqvist J, Kaprio J, Toga AW. Mapping heritability and molecular genetic associations with cortical features using probabilistic brain atlases: methods and applications to schizophrenia. Neuroinformatics. 2006; 4(1):5-19. PMID: 16595856.
      View in: PubMed
    219. Cannon T, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol. 2006; 2:267-90. PMID: 17716071.
      View in: PubMed
    220. Hirvonen J, van Erp TG, Huttunen J, Någren K, Huttunen M, Aalto S, Lönnqvist J, Kaprio J, Cannon T, Hietala J. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia. Psychiatry Res. 2006 Jan 30; 146(1):13-20. PMID: 16361088.
      View in: PubMed
    221. O'Brien MP, Gordon JL, Bearden CE, Lopez SR, Kopelowicz A, Cannon T. Positive family environment predicts improvement in symptoms and social functioning among adolescents at imminent risk for onset of psychosis. Schizophr Res. 2006 Jan 31; 81(2-3):269-75. PMID: 16309893.
      View in: PubMed
    222. Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon T, Silva AJ. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol. 2005 Nov 08; 15(21):1961-7. PMID: 16271875.
      View in: PubMed
    223. Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon T. The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res. 2005 Nov 01; 79(1):117-25. PMID: 16276559.
      View in: PubMed
    224. Cannon T. Clinical and genetic high-risk strategies in understanding vulnerability to psychosis. Schizophr Res. 2005 Nov 01; 79(1):35-44. PMID: 16054805.
      View in: PubMed
    225. Cannon T, Hennah W, van Erp TG, Thompson PM, Lonnqvist J, Huttunen M, Gasperoni T, Tuulio-Henriksson A, Pirkola T, Toga AW, Kaprio J, Mazziotta J, Peltonen L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry. 2005 Nov; 62(11):1205-13. PMID: 16275808.
      View in: PubMed
    226. Cannon T, Glahn DC, Kim J, Van Erp TG, Karlsgodt K, Cohen MS, Nuechterlein KH, Bava S, Shirinyan D. Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory in patients with schizophrenia. Arch Gen Psychiatry. 2005 Oct; 62(10):1071-80. PMID: 16203952.
      View in: PubMed
    227. Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon T. The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res. 2005 Sep 15; 77(2-3):141-9. PMID: 15905071.
      View in: PubMed
    228. Pirkola T, Tuulio-Henriksson A, Glahn D, Kieseppä T, Haukka J, Kaprio J, Lönnqvist J, Cannon T. Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol Psychiatry. 2005 Dec 15; 58(12):930-6. PMID: 16112657.
      View in: PubMed
    229. Meyer SE, Bearden CE, Lux SR, Gordon JL, Johnson JK, O'Brien MP, Niendam TA, Loewy RL, Ventura J, Cannon T. The psychosis prodrome in adolescent patients viewed through the lens of DSM-IV. J Child Adolesc Psychopharmacol. 2005 Jun; 15(3):434-51. PMID: 16092909.
      View in: PubMed
    230. Karlsgodt KH, Shirinyan D, van Erp TG, Cohen MS, Cannon T. Hippocampal activations during encoding and retrieval in a verbal working memory paradigm. Neuroimage. 2005 May 01; 25(4):1224-31. PMID: 15850740.
      View in: PubMed
    231. Hirvonen J, van Erp TG, Huttunen J, Aalto S, Någren K, Huttunen M, Lönnqvist J, Kaprio J, Hietala J, Cannon T. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry. 2005 Apr; 62(4):371-8. PMID: 15809404.
      View in: PubMed
    232. Cannon T. The inheritance of intermediate phenotypes for schizophrenia. Curr Opin Psychiatry. 2005 Mar; 18(2):135-40. PMID: 16639165.
      View in: PubMed
    233. Kieseppä T, Tuulio-Henriksson A, Haukka J, Van Erp T, Glahn D, Cannon T, Partonen T, Kaprio J, Lönnqvist J. Memory and verbal learning functions in twins with bipolar-I disorder, and the role of information-processing speed. Psychol Med. 2005 Feb; 35(2):205-15. PMID: 15841678.
      View in: PubMed
    234. Schnack HG, van Haren NE, Hulshoff Pol HE, Picchioni M, Weisbrod M, Sauer H, Cannon T, Huttunen M, Murray R, Kahn RS. Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum Brain Mapp. 2004 Aug; 22(4):312-20. PMID: 15202109.
      View in: PubMed
    235. Paunio T, Tuulio-Henriksson A, Hiekkalinna T, Perola M, Varilo T, Partonen T, Cannon T, Lönnqvist J, Peltonen L. Search for cognitive trait components of schizophrenia reveals a locus for verbal learning and memory on 4q and for visual working memory on 2q. Hum Mol Genet. 2004 Aug 15; 13(16):1693-702. PMID: 15198991.
      View in: PubMed
    236. Bearden CE, van Erp TG, Monterosso JR, Simon TJ, Glahn DC, Saleh PA, Hill NM, McDonald-McGinn DM, Zackai E, Emanuel BS, Cannon T. Regional brain abnormalities in 22q11.2 deletion syndrome: association with cognitive abilities and behavioral symptoms. Neurocase. 2004 Jun; 10(3):198-206. PMID: 15788257.
      View in: PubMed
    237. Kim J, Glahn DC, Nuechterlein KH, Cannon T. Maintenance and manipulation of information in schizophrenia: further evidence for impairment in the central executive component of working memory. Schizophr Res. 2004 Jun 01; 68(2-3):173-87. PMID: 15099601.
      View in: PubMed
    238. van Erp TG, Saleh PA, Huttunen M, Lönnqvist J, Kaprio J, Salonen O, Valanne L, Poutanen VP, Standertskjöld-Nordenstam CG, Cannon T. Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry. 2004 Apr; 61(4):346-53. PMID: 15066892.
      View in: PubMed
    239. Thompson PM, Hayashi KM, Sowell ER, Gogtay N, Giedd JN, Rapoport JL, de Zubicaray GI, Janke AL, Rose SE, Semple J, Doddrell DM, Wang Y, van Erp TG, Cannon T, Toga AW. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage. 2004; 23 Suppl 1:S2-18. PMID: 15501091.
      View in: PubMed
    240. Johnson JK, Tuulio-Henriksson A, Pirkola T, Huttunen MO, Lönnqvist J, Kaprio J, Cannon T. Do schizotypal symptoms mediate the relationship between genetic risk for schizophrenia and impaired neuropsychological performance in co-twins of schizophrenic patients? Biol Psychiatry. 2003 Dec 01; 54(11):1200-4. PMID: 14643087.
      View in: PubMed
    241. Kieseppä T, van Erp TG, Haukka J, Partonen T, Cannon T, Poutanen VP, Kaprio J, Lönnqvist J. Reduced left hemispheric white matter volume in twins with bipolar I disorder. Biol Psychiatry. 2003 Nov 01; 54(9):896-905. PMID: 14573317.
      View in: PubMed
    242. Niendam TA, Bearden CE, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon T. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry. 2003 Nov; 160(11):2060-2. PMID: 14594759.
      View in: PubMed
    243. Hietala J, Cannon T, van Erp TG, Syvälahti E, Vilkman H, Laakso A, Vahlberg T, Alakare B, Räkköläinen V, Salokangas RK. Regional brain morphology and duration of illness in never-medicated first-episode patients with schizophrenia. Schizophr Res. 2003 Nov 01; 64(1):79-81. PMID: 14511804.
      View in: PubMed
    244. Tuulio-Henriksson A, Arajärvi R, Partonen T, Haukka J, Varilo T, Schreck M, Cannon T, Lönnqvist J. Familial loading associates with impairment in visual span among healthy siblings of schizophrenia patients. Biol Psychiatry. 2003 Sep 15; 54(6):623-8. PMID: 13129657.
      View in: PubMed
    245. Glahn DC, Therman S, Manninen M, Huttunen M, Kaprio J, Lönnqvist J, Cannon T. Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry. 2003 Apr 01; 53(7):624-6. PMID: 12679242.
      View in: PubMed
    246. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003; 29(4):703-15. PMID: 14989408.
      View in: PubMed
    247. Cannon T, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Huttunen MO, Keshavan MS, Seidman LJ, Tsuang MT. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull. 2003; 29(4):653-69. PMID: 14989405.
      View in: PubMed
    248. Gasperoni TL, Ekelund J, Huttunen M, Palmer CG, Tuulio-Henriksson A, Lönnqvist J, Kaprio J, Peltonen L, Cannon T. Genetic linkage and association between chromosome 1q and working memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 01; 116B(1):8-16. PMID: 12497606.
      View in: PubMed
    249. Narr KL, van Erp TG, Cannon T, Woods RP, Thompson PM, Jang S, Blanton R, Poutanen VP, Huttunen M, Lönnqvist J, Standerksjöld-Nordenstam CG, Kaprio J, Mazziotta JC, Toga AW. A twin study of genetic contributions to hippocampal morphology in schizophrenia. Neurobiol Dis. 2002 Oct; 11(1):83-95. PMID: 12460548.
      View in: PubMed
    250. Van Erp TG, Saleh PA, Rosso IM, Huttunen M, Lönnqvist J, Pirkola T, Salonen O, Valanne L, Poutanen VP, Standertskjöld-Nordenstam CG, Cannon T. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry. 2002 Sep; 159(9):1514-20. PMID: 12202271.
      View in: PubMed
    251. Tuulio-Henriksson A, Haukka J, Partonen T, Varilo T, Paunio T, Ekelund J, Cannon T, Meyer JM, Lönnqvist J. Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia. Am J Med Genet. 2002 Jul 08; 114(5):483-90. PMID: 12116181.
      View in: PubMed
    252. Cannon T, Huttunen MO, Dahlström M, Larmo I, Räsänen P, Juriloo A. Antipsychotic drug treatment in the prodromal phase of schizophrenia. Am J Psychiatry. 2002 Jul; 159(7):1230-2. PMID: 12091205.
      View in: PubMed
    253. Narr KL, Cannon T, Woods RP, Thompson PM, Kim S, Asunction D, van Erp TG, Poutanen VP, Huttunen M, Lönnqvist J, Standerksjöld-Nordenstam CG, Kaprio J, Mazziotta JC, Toga AW. Genetic contributions to altered callosal morphology in schizophrenia. J Neurosci. 2002 May 01; 22(9):3720-9. PMID: 11978848.
      View in: PubMed
    254. Cannon T, van Erp TG, Glahn DC. Elucidating continuities and discontinuities between schizotypy and schizophrenia in the nervous system. Schizophr Res. 2002 Mar 01; 54(1-2):151-6. PMID: 11853989.
      View in: PubMed
    255. Cannon T, Thompson PM, van Erp TG, Toga AW, Poutanen VP, Huttunen M, Lonnqvist J, Standerskjold-Nordenstam CG, Narr KL, Khaledy M, Zoumalan CI, Dail R, Kaprio J. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A. 2002 Mar 05; 99(5):3228-33. PMID: 11867725; PMCID: PMC122501.
    256. Carter JW, Schulsinger F, Parnas J, Cannon T, Mednick SA. A multivariate prediction model of schizophrenia. Schizophr Bull. 2002; 28(4):649-82. PMID: 12795497.
      View in: PubMed
    257. Cannon T, van Erp TG, Rosso IM, Huttunen M, Lönnqvist J, Pirkola T, Salonen O, Valanne L, Poutanen VP, Standertskjöld-Nordenstam CG. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry. 2002 Jan; 59(1):35-41. PMID: 11779280.
      View in: PubMed
    258. Cannon T, Rosso IM. Levels of analysis in etiological research on schizophrenia. Dev Psychopathol. 2002; 14(3):653-66. PMID: 12349878.
      View in: PubMed
    259. Schiffman J, LaBrie J, Carter J, Cannon T, Schulsinger F, Parnas J, Mednick S. Perception of parent-child relationships in high-risk families, and adult schizophrenia outcome of offspring. J Psychiatr Res. 2002 Jan-Feb; 36(1):41-7. PMID: 11755460.
      View in: PubMed
    260. Thompson P, Cannon T, Toga AW. Mapping genetic influences on human brain structure. Ann Med. 2002; 34(7-8):523-36. PMID: 12553492.
      View in: PubMed
    261. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Doddrell DM, Cannon T, Toga AW. DETECTING DYNAMIC AND GENETIC EFFECTS ON BRAIN STRUCTURE USING HIGH-DIMENSIONAL CORTICAL PATTERN MATCHING. Proc IEEE Int Symp Biomed Imaging. 2002 Jan 01; 2002:473-476. PMID: 19759832.
      View in: PubMed
    262. Thompson P, Rapoport JL, Cannon T, Toga AW. IMAGING THE BRAIN AS SCHIZOPHRENIA DEVELOPS: DYNAMIC & GENETIC BRAIN MAPS. Prim psychiatry. 2002 Jan 01; 9(11):40-47. PMID: 20514148.
      View in: PubMed
    263. Cannon T, Gasperoni TL, van Erp TG, Rosso IM. Quantitative neural indicators of liability to schizophrenia: implications for molecular genetic studies. Am J Med Genet. 2001 Jan 08; 105(1):16-9. PMID: 11424984.
      View in: PubMed
    264. Cannon T, Huttunen MO, Lonnqvist J, Tuulio-Henriksson A, Pirkola T, Glahn D, Finkelstein J, Hietanen M, Kaprio J, Koskenvuo M. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet. 2000 Aug; 67(2):369-82. PMID: 10880296; PMCID: PMC1287184.
    265. Cannon T, Rosso IM, Hollister JM, Bearden CE, Sanchez LE, Hadley T. A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull. 2000; 26(2):351-66. PMID: 10885636.
      View in: PubMed
    266. Cannon T, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T. Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull. 2000; 26(2):379-93. PMID: 10885638.
      View in: PubMed